Peter Johnson
National clinical director for cancer, Cancer Research UK
Professor Peter Johnson is the director of the Southampton Cancer Research UK Centre. He is a leading expert in lymphoma, a cancer that affects the body’s disease-fighting white blood cells.
Professor Johnson recently led a clinical trial for patients with advanced Hodgkin lymphoma. He was looking at how a sophisticated type of imaging early on during treatment could help predict how well tumours were responding to chemotherapy. The findings will allow doctors to tailor treatment to each individual patient, meaning better outcomes and fewer side effects.
Visit website: https://www.cancerresearchuk.org/our-research/researchers/professor-peter-johnson
See also: Cancer Research UK - Independent cancer charity focused on saving lives through research, influence and information
Details last updated 06-May-2020
Peter Johnson News
AI doctor's assistant speeds up cancer detection in England by 8%
The Guardian - 21-Jul-2024
C the Signs spots hidden patterns in patient records, leading to faster and early cancer diagnoses
Read more...New drug offers hope for thousands of women at risk of breast cancer
BBC - 06-Nov-2023
Anastrozole could prevent risk of disease by 50% among eligible women in England
Read more...New study spots cancer tumors in very early stages by simple blood test
Guardian - 25-Jun-2021
Early stage detection of cancer has highest chance of cure
Read more...Nasal swab and blood test for early detection of lung cancer
Evening Standard - 11-Jun-2021
People in Hampshire and Yorkshire will be invited for participation in the trial
Read more...The switch from chemotherapy to hormone treatments for prostate cancer
BBC - 06-May-2020
A safer and more immune-friendly precision-medicine approach for cancer
Read more...